Targeted therapies in the management of metastatic bladder cancer.
The management of metastatic urothelial carcinoma (UC) of the bladder is a common and complex clinical challenge. Despite the fact that UC is one of the most frequent tumors in the population, long term survival for metastatic disease remains low, and chemotherapy is curative for only a small minority of patients. UC is genetically heterogeneous, and it is surrounded by a complex tissue microenvironment. The problems of clinical practice in the field of metastatic bladder cancer have begun to stimulate translational research. Advances in the understanding of the molecular biology of urothelial cancer continue to contribute to the identification of molecular pathways upon which new therapeutic approaches can be targeted. New agents and strategies have recently been developed which can direct the most appropriate choice of treatment for advanced disease. A review of literature published on the targeted therapy for metastatic bladder cancer is presented, focusing on the molecular pathways shut down by the new therapeutic agents.
Fassan
Matteo
M
Department of Urology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.
Trabulsi
Edouard J
EJ
Gomella
Leonard G
LG
Baffa
Raffaele
R
Nat Rev Drug Discov. 2006 Jan;5(1):37-50
16485345
Int J Cancer. 1999 Apr 20;84(2):169-73
10096250
Acta Oncol. 2002;41(3):282-8
12195748
Oncogene. 1991 May;6(5):789-95
2052357
Oncogene. 1991 Dec;6(12):2305-9
1766677
Lancet Oncol. 2006 Jan;7(1):15
16408368
Cancer. 1998 Feb 15;82(4):715-23
9477105
Clin Cancer Res. 1998 Apr;4(4):829-34
9563875
Cytopathology. 1995 Oct;6(5):361-2
8785377
Br J Cancer. 2002 Sep 9;87(6):654-8
12237776
Cancer Lett. 2004 Nov 25;215(2):209-20
15488640
Eur Urol. 1997;32(4):487-93
9412812
In Vivo. 2001 Mar-Apr;15(2):169-73
11317523
J Urol. 2001 Oct;166(4):1275-9
11547057
Int J Mol Med. 2006 Jan;17(1):3-13
16328005
J Natl Cancer Inst. 1997 May 21;89(10):724-30
9168188
J Urol. 1998 Sep;160(3 Pt 1):645-59
9720515
Oncogene. 2005 May 12;24(21):3484-91
15735745
J Clin Oncol. 2006 Dec 10;24(35):5552-64
17158541
Eur J Cancer. 2001 Sep;37 Suppl 4:S9-15
11597399
Clin Cancer Res. 2006 Jan 1;12(1):144-51
16397036
J Negat Results Biomed. 2004 Nov 17;3:5
15548325
J Clin Oncol. 2002 Sep 15;20(18 Suppl):1S-13S
12235219
Nat Med. 2002 Mar;8(3):282-8
11875500
Eur Urol. 1996;29(4):470-6
8791057
Br J Cancer. 1999 May;80(5-6):904-8
10360673
Anticancer Res. 1997 Mar-Apr;17(2B):1293-6
9137488
Oncogene. 2001 Feb 8;20(6):686-91
11314002
Nat Med. 2000 Aug;6(8):879-85
10932224
Int J Cancer. 2002 Dec 10;102(5):514-8
12432555
Clin Cancer Res. 2004 Jul 15;10(14):4874-84
15269164
Cell. 1991 Jun 14;65(6):1063-72
1828393
Int J Cancer. 1998 Apr 13;76(2):189-93
9537579
Ann Oncol. 2001;12 Suppl 1:S81-7
11521727
Int J Cancer. 1993 Feb 1;53(3):365-70
8428790
Proc Natl Acad Sci U S A. 2002 Aug 20;99(17):11399-404
12177446
Mol Pathol. 2001 Aug;54(4):215-21
11477133
J Urol. 1999 Jul;162(1):69-73
10379742
Nature. 1986 Oct 16-22;323(6089):643-6
2877398
Anticancer Res. 2001 Sep-Oct;21(5):3167-73
11848469
Cancer Res. 1996 Jun 15;56(12):2721-5
8665502
Hum Pathol. 2000 Jun;31(6):751-60
10872671
Br J Cancer. 2004 Apr 19;90(8):1679-85
15083203
Ann Oncol. 1994 Nov;5(9):835-40
7848886
J Clin Oncol. 2004 Mar 15;22(6):1014-24
14981102
Int J Biol Markers. 2007 Jan-Mar;22(1 Suppl 4):S3-9
17520579
Cancer. 1991 Mar 15;67(6):1525-31
2001540
J Clin Oncol. 2003 Jun 15;21(12):2247-53
12805322
Br J Cancer. 1993 Nov;68(5):1029-35
8217593
Br J Cancer. 1995 May;71(5):907-13
7734314
J Exp Clin Cancer Res. 2006 Jun;25(2):145-60
16918124
Hum Gene Ther. 2000 Sep 20;11(14):2009-24
11020800
Urol Int. 1992;48(4):365-71
1357809
Urology. 2000 Oct 1;56(4):689-95
11018640
Oncogene. 1998 Jun 18;16(24):3215-8
9671402
J Urol. 2005 Feb;173(2):604-9
15643273
Cancer Res. 1990 Apr 15;50(8):2530-7
1690599
Br J Cancer. 1994 Apr;69(4):680-6
7908215
Clin Cancer Res. 2000 May;6(5):2053-63
10815932
Urol Oncol. 2003 Nov-Dec;21(6):456-62
14693272
Oncogene. 2007 May 14;26(22):3291-310
17496923
Br J Cancer. 1998 Jul;78(2):215-20
9683296
Clin Cancer Res. 2001 Aug;7(8):2440-7
11489824
Nat Rev Cancer. 2005 Sep;5(9):713-25
16110317
Eur Urol. 1992;22(2):158-62
1362155
Cell. 1991 Jun 14;65(6):1053-61
1828392
J Clin Pathol. 2005 Apr;58(4):367-71
15790699
Eur Urol. 1998;33(4):424-30
9612689
Annu Rev Biochem. 1989;58:137-71
2570548
Am J Pathol. 2002 Apr;160(4):1345-52
11943719
Clin Cancer Res. 2000 Mar;6(3):747-53
10741693
Clin Cancer Res. 2002 Jan;8(1):171-9
11801555
Cancer. 1992 Nov 15;70(10):2493-8
1358427
J Clin Oncol. 1995 Jun;13(6):1384-90
7751883
Cancer. 2003 Apr 15;97(8 Suppl):2090-8
12673701
Oncol Rep. 2003 May-Jun;10(3):571-6
12684626
Nat Clin Pract Oncol. 2006 Jan;3(1):24-40
16407877
Anticancer Drugs. 2005 Jun;16(5):475-81
15846112
Cancer Control. 2000 Jul-Aug;7(4):347-56
10895129
J Natl Cancer Inst. 1995 Jan 18;87(2):129-33
7707384
J Clin Oncol. 2006 Apr 20;24(12):1892-7
16622264
Oncogene. 2006 Aug 28;25(38):5233-43
16936742
Nature. 1997 Jan 9;385(6612):123-5
8990112
Am J Pathol. 1999 Mar;154(3):755-65
10079253
Am J Pathol. 1993 Nov;143(5):1389-97
7901994
Clin Cancer Res. 2004 Nov 15;10(22):7607-12
15569992
Cancer Biol Ther. 2003 Jul-Aug;2(4 Suppl 1):S84-95
14508085
J Clin Oncol. 1998 Aug;16(8):2722-7
9704723
J Urol. 1996 Jan;155(1):321-6
7490879
Br J Cancer. 1991 Apr;63(4):601-8
1673627
Br J Cancer. 1997;75(12):1788-92
9192983
Br J Cancer. 2002 Jan 7;86(1):5-11
11857003
Cancer Lett. 2002 Dec 1;186(1):115-20
12183083
Nat Genet. 1999 Sep;23(1):18-20
10471491
J Urol. 2001 Aug;166(2):482-7
11458051
J Natl Cancer Inst. 1994 Sep 7;86(17):1325-30
8064890
Cancer Res. 2003 Feb 15;63(4):760-5
12591722
BJU Int. 2005 May;95(7):982-6
15839918
J Urol. 2003 Nov;170(5):2000-3
14532841
Histol Histopathol. 2007 Apr;22(4):349-63
17290345
Am J Pathol. 2000 Feb;156(2):419-24
10666370
Oncol Rep. 2001 Jan-Feb;8(1):9-15
11115562
Int J Cancer. 2002 Apr 1;98(4):539-46
11920613
Oncology. 1999 Apr;56(3):239-47
10202280
N Engl J Med. 1994 Nov 10;331(19):1259-64
7935683
J Clin Oncol. 1994 Nov;12(11):2264-70
7525883
J Clin Oncol. 1992 Jul;10(7):1066-73
1607913
Clin Colorectal Cancer. 2005 Sep;5(3):188-96
16197622
Cancer Res. 1997 Apr 1;57(7):1217-21
9102201
Am J Clin Pathol. 1994 Feb;101(2):166-76
7906919
Clin Cancer Res. 2002 Feb;8(2):464-70
11839665
Urol Res. 1997;25(1):9-17
9079740
Int J Cancer. 1993 Mar 12;53(5):781-4
8449603
Urol Oncol. 2004 Mar-Apr;22(2):93-101
15082004
Clin Cancer Res. 1999 Feb;5(2):257-65
10037173
World J Urol. 2006 Nov;24(5):543-56
17031652
Crit Rev Oncol Hematol. 2003 Jun 27;46 Suppl:S85-104
12850530
J Urol. 2001 Apr;165(4):1152-7
11257658
Semin Oncol. 2001 Oct;28(5 Suppl 16):67-79
11706398
Semin Surg Oncol. 1992 Sep-Oct;8(5):285-92
1462099
J Clin Oncol. 2002 Feb 15;20(4):957-65
11844817
J Natl Cancer Inst. 1992 Aug 19;84(16):1251-6
1640484
BJU Int. 2005 Apr;95(6):786-90
15794783
Genes Dev. 1993 Jul;7(7A):1126-32
8319905
J Urol. 2001 Oct;166(4):1291-5
11547060
Cancer Metastasis Rev. 2007 Dec;26(3-4):623-34
17726580
J Urol. 2005 Mar;173(3):683-90
15711244
Am J Clin Pathol. 1988 Sep;90(3):329-32
3046323
Br J Dermatol. 2005 Nov;153(5):900-10
16225598
J Natl Cancer Inst. 1992 Aug 19;84(16):1256-61
1640485
J Urol. 1995 Mar;153(3 Pt 2):919-25
7853575
Clin Cancer Res. 2001 Jul;7(7):1957-62
11448910
J Natl Cancer Inst. 1993 Jan 6;85(1):53-9
7677935
Science. 1991 May 3;252(5006):706-9
2024123
Br J Cancer. 2001 May 4;84(9):1242-51
11336477
Cancer Res. 1999 Jul 1;59(13):3245-50
10397272
Trends Mol Med. 2002;8(4 Suppl):S19-26
11927283
J Clin Oncol. 2000 Sep;18(17):3068-77
11001674
J Clin Oncol. 2007 Jun 1;25(16):2218-24
17538166
J Urol. 1991 Jan;145(1):45-50
1984097
J Clin Oncol. 1998 Jan;16(1):255-60
9440750
Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):9837-41
7937901
Clin Cancer Res. 2004 Mar 1;10(5):1835-42
15014038
Crit Rev Oncol Hematol. 2003 Jun 27;46 Suppl:S67-83
12850529
Science. 1991 Jul 5;253(5015):49-53
1905840
Oncol Rep. 2002 Mar-Apr;9(2):253-9
11836589
Oncogene. 2003 Sep 29;22(42):6609-20
14528286
J Clin Oncol. 2005 May 1;23(13):2879-81
15753457
BJU Int. 2006 Nov;98(5):1090-3
17034609
Br J Cancer. 1994 Jun;69(6):1120-5
7911031
Curr Opin Genet Dev. 2002 Feb;12(1):111-5
11790564
N Engl J Med. 1990 Apr 19;322(16):1129-38
2181313
Urol Int. 1995;55(2):63-7
8533197
Eur Urol. 1998;33(3):278-84
9555552
Am J Pathol. 1999 Jul;155(1):105-13
10393843
Clin Cancer Res. 2003 Apr;9(4):1546-56
12684431
Cancer. 2007 Mar 15;109(6):1097-105
17311305
J Urol. 1991 Feb;145(2):423-7
1988741
Nat Med. 1997 Jun;3(6):639-45
9176490
J Clin Oncol. 1998 Apr;16(4):1601-12
9552072
Int J Cancer. 2000 Nov 15;88(4):620-5
11058880
J Natl Cancer Inst. 1994 Sep 7;86(17):1331-5
8064891
Oncogene. 1999 Apr 22;18(16):2657-61
10353610
N Engl J Med. 2003 Aug 28;349(9):859-66
12944571
Eur Urol. 2005 Aug;48(2):202-5; discussion 205-6
15939524
Science. 1999 Dec 24;286(5449):2507-10
10617466
Oncology (Williston Park). 2003 Nov;17(11 Suppl 12):11-6
14682118
Cancer Chemother Pharmacol. 2007 Feb;59(2):183-95
16724239
Cancer. 1989 Dec 15;64(12):2448-58
2819654
Cancer Res. 2006 Feb 1;66(3):1611-9
16452220
Cancer Res. 1995 Jun 1;55(11):2422-30
7757996
Med Hypotheses. 2007;69(4):892-5
17368754
BJU Int. 1999 Mar;83(4):498-503
10210578
Front Biosci. 2007 Jan 01;12:826-38
17127340
Clin Cancer Res. 1999 Dec;5(12):4079-84
10632343
Crit Rev Oncol Hematol. 2003 Aug;47(2):195-206
12900012
Cancer. 1996 Oct 15;78(8):1762-74
8859190
Nature. 1992 Jul 2;358(6381):80-3
1614537
J Natl Cancer Inst. 2002 Sep 4;94(17):1320-9
12208897
J Natl Cancer Inst. 1998 Jul 15;90(14):1072-9
9672255
Urology. 2003 Jun;61(6):1140-5
12809883
J Clin Oncol. 1998 May;16(5):1844-8
9586899
CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66
17237035
Oncogene. 1998 Sep 3;17(9):1167-72
9764827
Cancer. 1990 Apr 1;65(7):1619-25
2311071
Clin Cancer Res. 2000 Aug;6(8):3131-8
10955794
Clin Cancer Res. 2000 Dec;6(12):4874-84
11156247
Cancer. 2002 Sep 1;95(5):1009-15
12209684